Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Christoph Stettler(University of Bern), Simon Wandel, Sabin Allemann(University of Bern), Adnan Kastrati(Deutsches Herzzentrum der Charité), Marie Claude Morice(Hôpital Privé Jacques Cartier), Albert Schömig(Deutsches Herzzentrum der Charité), Matthias Pfisterer(University Hospital of Basel), Gregg W. Stone(Cardiovascular Research Foundation), Martin B. Leon(Columbia University Irving Medical Center), José Suárez de Lezo(Hospital Universitario Reina Sofía), Jean‐Jácques Goy(Hirslanden Clinique Cecil), Seung‐Jung Park(Asan Medical Center), Manel Sabaté(Hospital Clínico San Carlos), Maarten J. Suttorp(St. Antonius Ziekenhuis), Henning Kelbæk(Rigshospitalet), Christian Spaulding(Université Paris Cité), Maurizio Menichelli(IRCCS San Camillo Hospital), Paul Vermeersch(ZNA Middelheim Hospital), Maurits T. Dirksen(OLVG), Pavel Červinka(Masaryk University), Anna Sonia Petronio(University of Pisa), Alain Nordmann(University Hospital of Basel), Peter Diem(University Hospital of Bern), Bernhard Meier(University Hospital of Bern), Marcel Zwahlen, Stephan Reichenbach, Sven Trelle, Stephan Windecker(University of Bern), Peter Jüni(University of Bristol)
Cited by 1,428
Abstract
Related Papers
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca, Peter Buser et al.|Journal of the American College of Cardiology|2006|1.3k